Effect of Dapagliflozin in The Prevention of Iodinated Contrast Media Induced Acute Kidney Injury
Phase 3
Recruiting
- Conditions
- Acute kidney injury caused by iodinated contrast agents.Acute kidney failure
- Registration Number
- IRCT20170609034406N11
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Adults aged 18 years or older
Patients who are candidates for CT scan and receive Iodized Contrast Agents
Exclusion Criteria
Patients with underlying renal failure with GFR less than 30
Patients with liver failure (Child-Pugh stage B and C)
Patients with heart failure
Pregnant and lactating women
The presence of chronic infection or autoimmune diseases
History of taking Dapagliflozin
Diabetic patients with Diabetic foot ulcers
Patients are susceptible to ketoacidosis
Alcoholic patients
Patients with pancreatic failure
History of allergy to Dapagliflozin
Patients with osteoporosis
Concomitant use of nephrotoxic drugs such as Calcineurin Inhibitors , Aminoglycosides, Vancomycin, Amphotericin B
Participation in other clinical studuies
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method